User's Manual

Table Of Contents
TELEMETRY TRANSMITTER (96281) OPERATIONS MANUAL 1-4
I NTRODUCTION
Warnings, Cautions, and Notes
This chapter includes warnings, cautions, and notes specifically related to digital telemetry. Refer
to the ECG chapter in the Clinical Parameters Operations Manual, P/N 070-2113-xx, for warnings
and cautions and cautionary disclosures related to ECG. Refer to the product specifications
chapter for warnings and cautions and cautionary disclosures that apply to electrodes and
leadwires, defibrillators (including automatic implantable cardiac defibrillators), pacemakers,
electrosurgical activity, several physiological parameters, or to the monitoring system itself.
Obey these warnings and cautions to avoid injury or death to individuals or damage to equipment.
Warnings:
Review the device prior to each and every procedure. If it shows signs of abuse then
either make sure the device is repaired in an appropriate manner, serviced, or retired
from use.
Medical telemetry spectrum allocations may be assigned to frequencies already
allotted to other priority users. Radio frequency interference from other products
may disrupt or impede telemetry patient monitoring during the life of this equipment.
You are urged to regularly consult with applicable local and federal regulatory
agencies (e.g., FCC, FDA) regarding the locations and frequencies of other spectrum
users in your geographic area. A Spacelabs Healthcare field service engineer may be
able to assist you in reconfiguring your equipment frequencies to reduce the risk of
interference. Spacelabs Healthcare cannot, and does not, guarantee interference-free
telemetry operation.
Telemetry systems may be more susceptible to interference than hardwired systems;
this may impact signal quality.
The transmitters do not currently support inhibition of their pacer detection
functionality. Since Left Ventricular Assist Devices (LVADs) can generate
electromagnetic noise having similar characteristics to pacemaker artifact, users
should pay particular attention to ECG traces acquired using these transmitters
when an LVAD is in use.
Do not use the 96281 telemetry transmitter during magnetic resonance imaging (MRI)
procedures. MRI operations will cause damage to the transmitter.
Remove the 96281 telemetry transmitter from any patient before beginning an MRI
procedure.
Operation of hand-held, wireless telephone equipment (cordless telephones,
cellular telephones) near telemetry systems may cause interference and should be
discouraged. While personal communication devices are turned on, a separation of
>2 meters (>6.5 feet) should be maintained between personal communication
devices and interior walls, the patient cables, and any electronic medical device to
which the patient may be connected. Patients should not use any type of electronic
communication equipment while connected to any electronic medical device without
an on-site evaluation by the biomedical staff. Two-way radio equipment and other
personal communication devices must be evaluated on site to determine if additional
space limitations are needed.
D R A F T
22 June 2012